cambridge's bluebird bio licenses delivery tech to novartis, gsk.
.
the state launched a review into the newspaper�s findings in late april.
.treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk (file pic).
.
"it has been a long two years and throughout that time the western trust has not been assisting us in trying to understand the circumstances around our mother's death..